ScoreWhy is Sino Biological Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -13.76% and Operating profit at -38.60% over the last 5 years
2
Positive results in Mar 26
- NET SALES(HY) At CNY 371.54 MM has Grown at 22.21%
- RAW MATERIAL COST(Y) Fallen by -17.61% (YoY)
- PRE-TAX PROFIT(Q) At CNY 37.43 MM has Grown at 55.54%
3
With ROE of 2.48%, it has a attractive valuation with a 0.66 Price to Book Value
- Over the past year, while the stock has generated a return of -6.54%, its profits have risen by 28.7% ; the PEG ratio of the company is 0.9
- At the current price, the company has a high dividend yield of 8.7
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -6.54% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sino Biological Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sino Biological Inc. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sino Biological Inc.
-6.54%
-0.14
31.75%
China Shanghai Composite
16.78%
1.20
13.96%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-13.76%
EBIT Growth (5y)
-38.60%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.11
Tax Ratio
9.18%
Dividend Payout Ratio
428.12%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
129.55%
ROE (avg)
16.65%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
0.66
EV to EBIT
2.33
EV to EBITDA
1.38
EV to Capital Employed
0.12
EV to Sales
0.36
PEG Ratio
0.92
Dividend Yield
8.69%
ROCE (Latest)
5.31%
ROE (Latest)
2.48%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET SALES(HY)
At CNY 371.54 MM has Grown at 22.21%
RAW MATERIAL COST(Y)
Fallen by -17.61% (YoY
PRE-TAX PROFIT(Q)
At CNY 37.43 MM has Grown at 55.54%
-4What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -60.11 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.28 times
OPERATING PROFIT(Q)
Lowest at CNY 30.04 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 16.38 %
Here's what is working for Sino Biological Inc.
Net Sales
At CNY 371.54 MM has Grown at 22.21%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 37.43 MM has Grown at 55.54%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Raw Material Cost
Fallen by -17.61% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Sino Biological Inc.
Operating Profit
Lowest at CNY 30.04 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 16.38 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Debt-Equity Ratio
Highest at -60.11 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 3.28 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
